PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
16-Oct-2025 Cycle Pharmaceuticals Launches Its First Oncology Product, PHYRAGO™ (dasatinib) Tablets, in the US Businesswire
16-Oct-2025 New Roquette Pharmaceutical Innovation Center to Strengthen Latin America as Collaborative Hub Businesswire
16-Oct-2025 ME Therapeutics Granted Licence for CD22 Nanobody Asset to Expand Next-Gen In Vivo CAR Cell Therapy Program Businesswire
16-Oct-2025 Enveric Biosciences Further Enhances Intellectual Property Estate with New U.S. Patent Issuance Businesswire
16-Oct-2025 Vistagen to Present at The Menopause Society 2025 Annual Meeting Businesswire
16-Oct-2025 Weave Bio Secures $20M Series A Funding to Enhance Its AI-Native Regulatory Platform Businesswire
16-Oct-2025 OmniAb to Participate in Three Investor Conferences in November Businesswire
16-Oct-2025 bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer Businesswire
16-Oct-2025 Clarametyx Biosciences Announces Completion of Enrollment in Phase 2a Study of CMTX-101 in Cystic Fibrosis Businesswire
16-Oct-2025 Thermo Fisher Scientific to Accelerate Life Science Breakthroughs with OpenAI Businesswire
16-Oct-2025 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
16-Oct-2025 Doron Therapeutics Announces First Patients Dosed in Phase 3 Study of MOTYS (PTP-001) for the Treatment of Osteoarthritis of the Knee Businesswire
16-Oct-2025 Adicet Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Treatment-Refractory Rheumatoid Arthritis (RA) Businesswire
16-Oct-2025 Consumer Healthcare Products Association Joins the International Collaboration on Cosmetics Safety Businesswire
16-Oct-2025 Recur Software Acquires Cognidox to Invest in Growth and AI Capabilities for Life Sciences and High Tech Markets Businesswire
16-Oct-2025 Aptar Named Among Top 100 of the ‘World’s Top Companies for Women 2025’ by Forbes Businesswire
15-Oct-2025 VeraMorph Awarded an SBIR Fast Track Grant by NCI Towards Commercialization of the First Effective Oral Fulvestrant Therapy for ER+ Metastatic Breast Cancer Businesswire
15-Oct-2025 Thermo Fisher Scientific Fuels the Future of Multi-omics Research with the Launch of Next-Generation Microarray Solution Businesswire
15-Oct-2025 Baxter to Host Third-Quarter 2025 Financial Results Conference Call for Investors Businesswire
15-Oct-2025 ON24 Announces Date for Third Quarter 2025 Earnings Release and Conference Call Businesswire